World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
35921
World Ranking
17360
National Ranking
47

Overview

Stephanos J. Hadziyannis is affiliated with the National and Kapodistrian University of Athens in Greece. Their research primarily focuses on the fields of Medicine, with significant work in Epidemiology, Hepatology, and Hematology.

The scientist's work has concentrated on topics related to Hepatitis C virus research, Hepatitis B virus studies, liver disease diagnosis and treatment, and aspects of blood groups and transfusion.

Recent publications include the following papers:

  • Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study (2021) published in Liver International
  • Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B (2022) published in Virology Journal
  • Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B (2020) published in Expert Review of Gastroenterology & Hepatology
  • Early Predictors of Anemia in Patients With Hepatitis C Genotype 1 Treated With Peginterferon Alfa-2a (40KD) Plus Ribavirin (2020) published in UNC Libraries

Frequent co-authors collaborating with Hadziyannis include:

  • Emilia Hadziyannis
  • Μargarita Papatheodoridi
  • George Papatheodoridis
  • Tung-Hung Su
  • Chun-Hsun Liao

Stephanos J. Hadziyannis has published multiple articles in several academic venues, notably:

  • Liver International
  • Virology Journal
  • Expert Review of Gastroenterology & Hepatology
  • UNC Libraries

Best Publications

  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

    Hadziyannis Sj;Sette H;Morgan Tr;Balan

  • EASL Clinical Practice Guidelines: Management of chronic hepatitis B

    C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban

  • Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Jeff Linnen;John Wages;Zhen-Yong Zhang-Keck;Kirk E. Fry

  • MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

    W.F Carman;S Hadziyannis;M.J Mcgarvey;M.R Jacyna

  • Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

    Patrick Marcellin;George K.K. Lau;Ferruccio Bonino;Patrizia Farci

  • Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting–Tsung Chang

  • Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.

    David A. Shafritz;Daniel Shouval;Howard I. Sherman;Stefanos J. Hadziyannis

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

    Maurizia Rossana Brunetto;Francesco Moriconi;Ferruccio Bonino;George K. K. Lau

  • Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy†‡§

    Donald M. Jensen;Timothy R. Morgan;Patrick Marcellin;Paul J. Pockros

  • Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B

    Giovanna Fattovich;Giuliano Giustina;Solko W. Schalm;Stephanos Hadziyannis

  • Efficacy of long‐term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B

    Stephanos J. Hadziyannis;George V. Papatheodoridis;Evangelini Dimou;Andreas Laras

  • Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti‐HBe Positive Carriers of Hepatitis B Virus

    Stephanos J. Hadziyannis;Harvey M. Lieberman;Gerassimos G. Karvountzis;David A. Shafritz

  • Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.

    Irene Rapti;Evangelini Dimou;Panayota Mitsoula;Stephanos J. Hadziyannis

  • Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

    Patrick Marcellin;Ferruccio Bonino;George K.K. Lau;Patrizia Farci

  • The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B

    George V Papatheodoridis;Emanuel Manesis;Stephanos J Hadziyannis

  • Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study

    Giuseppe Realdi;Giovanna Fattovich;Stephanos Hadziyannis;Solko W. Schalm

  • Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil

    Chris Westland;William Delaney;Huiling Yang;Shan-shan Chen

  • A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-refractory Chronic Hepatitis B Patients

    Ting–Tsung Chang;Robert G. Gish;Stephanos J. Hadziyannis;Janusz Cianciara

Frequent Co-Authors

George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Ferruccio Bonino
Ferruccio Bonino National Research Council (CNR)
Mario Rizzetto
Mario Rizzetto University of Turin
Seng Gee Lim
Seng Gee Lim National University of Singapore
Howard C. Thomas
Howard C. Thomas Imperial College London
William F. Carman
William F. Carman University of Glasgow
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
George K. K. Lau
George K. K. Lau Humanity & Health
Peter Karayiannis
Peter Karayiannis University of Nicosia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore options for studying Medicine in the USA, consider the growing range of online nursing and healthcare degrees. For licensed nurses aiming to advance their education, there are rn to bsn online no clinicals accredited programs that remove the barrier of in-person clinical hours and offer added flexibility.

If you're looking to move into leadership or specialized practice, Doctor of Nursing Practice (DNP) programs may be of interest. Several dnp online programs allow students to graduate more quickly. For those seeking a less demanding path, some institutions offer easy dnp programs designed with student support and manageable coursework.

Entry-level healthcare careers are also expanding. For example, individuals pursuing practical nursing will find options like fast track lpn programs online, helping them earn credentials and enter the workforce faster. These online pathways offer a variety of career opportunities while balancing the demands of school and work.

Best Scientists Citing Stephanos J. Hadziyannis

Trending Scientists

Recently Published Articles